Niagen Bioscience, Inc.
DE ˙ DB ˙ US1710774076
2,70 € ↓ -0,30 (-10,00%)
2026-06-04
DEL PRIS
SecurityDE:OCD1 / Niagen Bioscience, Inc.
InstitutionMorgan Stanley
Latest Disclosed Ownership381,089 shares
Latest Disclosed Value $ 1,680,602
Morgan Stanley reports 56.70% decrease in ownership of OCD1 / Niagen Bioscience, Inc.

On May 15, 2026 - Morgan Stanley filed a 13F-HR form disclosing ownership of 381,089 shares of Niagen Bioscience, Inc. (DE:OCD1) valued at $1,333,812 USD as of March 31, 2026. The entity filed a previous 13F-HR/A on May 27, 2026 disclosing 880,124 shares of Niagen Bioscience, Inc.. This represents a change in shares of -56.70% during the quarter. The current value of the position is $1,028,940 USD.

Institutional Ownership: 13F and NPORT Filings

The Security and Class in the table below are shown exactly as filed by the investor. We do our best to track continuity of investments through acquisitions, and this will be reflected in the table as changes in names. In addition to descriptive data, performance of the investment is shown over time. To calculate quarterly performance, we first calculate cost basis of the shares purchased during the quarter, then use that to calculate gross profit. Quarterly return is Gross Profit / Starting Portfolio value.

Note that cost basis is calculated and stored in thousands, so small quarterly changes in shares frequently result in a cost basis of zero.

Upgrade to unlock premium data and export to Excel .

Disclosed Equity Positions (from 13F/NPORT Filings)
File
Date		 Effective
Date		Form Security Class ID Avg Price
Paid (Est)		 Reported
Shares		 ΔShares ΔShares
(%)		 Reported
Value
(x1000)		 ΔValue
(%)		 Alloc
(%)		 ΔAlloc ΔAlloc (%) Cost Basis
(x1000)		 Unrealized
Gain/Loss
(x1000)
2026-05-15 2026-03-31 13F NIAGEN BIOSCIENCE COM NEW 171077407 381,089 -499,035 -56.70 1,681 -69.98 0.0001
2026-05-27 2025-12-31 13F/A-1 NIAGEN BIOSCIENCE COM NEW 171077407 880,124 351,753 66.57 5,598 13.55 0.0003
2026-02-13 2025-12-31 13F NIAGEN BIOSCIENCE COM NEW 171077407 880,124 351,753 5,598 0.0003
2026-05-27 2025-09-30 13F/A-1 NIAGEN BIOSCIENCE COM NEW 171077407 528,371 -78,347 -12.91 4,930 -43.62 0.0003
2025-11-14 2025-09-30 13F NIAGEN BIOSCIENCE COM NEW 171077407 528,371 -78,347 4,930 0.0003
2025-08-15 2025-06-30 13F NIAGEN BIOSCIENCE COM NEW 171077407 606,718 341,773 129.00 8,743 378.23 0.0006
2025-05-15 2025-03-31 13F NIAGEN BIOSCIENCE COM NEW 171077407 264,945 110,071 71.07 1,828 122.66 0.0001
2025-05-15 2024-12-31 13F/A-1 CHROMADEX COM NEW 171077407 154,874 -8,753 -5.35 822 37.52 0.0001
2025-02-14 2024-12-31 13F CHROMADEX COM NEW 171077407 154,874 -8,753 822 0.0001
2025-05-14 2024-09-30 13F/A-2 CHROMADEX COM NEW 171077407 163,627 93,880 134.60 597 214.21 0.0000
2025-02-14 2024-09-30 13F/A-1 CHROMADEX COM NEW 171077407 163,627 93,880 597 0.0000
2024-11-14 2024-09-30 13F CHROMADEX COM NEW 171077407 163,627 93,880 597 0.0000
2025-05-14 2024-06-30 13F/A-2 CHROMADEX COM NEW 171077407 69,747 24,991 55.84 190 22.58 0.0000
2024-10-17 2024-06-30 13F/A-1 CHROMADEX COM NEW 171077407 69,747 24,991 190 0.0000
2024-08-14 2024-06-30 13F CHROMADEX COM NEW 171077407 69,747 24,991 190 0.0000
2024-10-17 2024-03-31 13F/A-2 CHROMADEX COM NEW 171077407 44,756 38,267 589.72 156 1,622.22 0.0000
2024-08-16 2024-03-31 13F/A-1 CHROMADEX COM NEW 171077407 44,756 38,267 156 0.0000
2024-05-15 2024-03-31 13F CHROMADEX COM NEW 171077407 44,756 38,267 156 0.0000
2024-08-16 2023-12-31 13F/A-1 CHROMADEX COM NEW 171077407 6,489 287 4.63 9 0.00 0.0000
2024-02-13 2023-12-31 13F CHROMADEX COM NEW 171077407 6,489 287 9 0.0000
2023-11-15 2023-09-30 13F CHROMADEX COM NEW 171077407 6,202 -2,271 -26.80 9 -30.77 0.0000
2023-08-14 2023-06-30 13F CHROMADEX COM NEW 171077407 8,473 -1,556 -15.52 13 -13.33 0.0000
2023-05-15 2023-03-31 13F CHROMADEX COM NEW 171077407 10,029 -4,667 -31.76 15 -37.50 0.0000
2023-02-14 2022-12-31 13F CHROMADEX COM NEW 171077407 14,696 -10,715 -42.17 25 -22.58 0.0000
2022-11-14 2022-09-30 13F CHROMADEX COM NEW 171077407 25,411 -129,871 -83.64 31 -88.03 0.0000
2022-10-27 2022-06-30 13F/A-1 CHROMADEX COM NEW 171077407 155,282 72,601 87.81 259 27.59 0.0000
2022-08-15 2022-06-30 13F CHROMADEX COM NEW 171077407 155,282 72,601 259 0.0000
2022-10-27 2022-03-31 13F/A-1 CHROMADEX COM NEW 171077407 82,681 -2,655 -3.11 203 -36.36 0.0000
2022-05-13 2022-03-31 13F CHROMADEX COM NEW 171077407 82,681 -2,655 203 0.0000
2022-02-14 2021-12-31 13F CHROMADEX COM NEW 171077407 85,336 -14,468 -14.50 319 -49.04 0.0000
2021-11-15 2021-09-30 13F CHROMADEX COM NEW 171077407 99,804 -48,084 -32.51 626 -57.04 0.0001
2021-08-23 2021-06-30 13F/A-1 CHROMADEX COM NEW 171077407 147,888 -215,756 -59.33 1,457 -57.08 0.0002
2021-08-16 2021-06-30 13F CHROMADEX COM NEW 171077407 147,888 -215,756 1,457 0.0002
2021-05-17 2021-03-31 13F CHROMADEX COM NEW 171077407 363,644 -358,581 -49.65 3,395 -2.08 0.0005
2021-02-16 2020-12-31 13F CHROMADEX COM NEW 171077407 722,225 84,167 13.19 3,467 35.54 0.0005
2020-11-13 2020-09-30 13F CHROMADEX COM NEW 171077407 638,058 171,900 36.88 2,558 19.53 0.0005
2020-08-14 2020-06-30 13F CHROMADEX COM NEW 171077407 466,158 453,136 3,479.77 2,140 4,995.24 0.0005
2020-05-26 2020-03-31 13F/A-1 CHROMADEX COM NEW 171077407 13,022 -51,875 -79.93 42 -84.95 0.0000
2020-05-15 2020-03-31 13F CHROMADEX COM NEW 171077407 13,022 -51,875 42 3.2265
2020-02-14 2019-12-31 13F CHROMADEX COM NEW 171077407 64,897 43,643 205.34 279 232.14 0.0001
2019-11-14 2019-09-30 13F CHROMADEX COM NEW 171077407 21,254 10,530 98.19 84 68.00 0.0000
2019-08-14 2019-06-30 13F CHROMADEX COM NEW 171077407 10,724 -52,557 -83.05 50 -81.13 0.0000
2019-05-15 2019-03-31 13F CHROMADEX COM NEW 171077407 63,281 -24,162 -27.63 265 -11.67 0.0001
2019-02-14 2018-12-31 13F CHROMADEX COM NEW 171077407 87,443 3,148 3.73 300 -17.13 0.0001
2019-04-23 2018-09-30 13F/A-2 CHROMADEX COM NEW 171077407 84,295 -22,211 -20.85 362 -8.35 0.0001
2018-11-20 2018-09-30 13F/A-1 CHROMADEX COM NEW 171077407 84,295 0 362 0.0001
2018-11-14 2018-09-30 13F CHROMADEX COM NEW 171077407 84,295 -22,211 362
2019-04-23 2018-06-30 13F/A-1 CHROMADEX COM NEW 171077407 106,506 -8,918 -7.73 395 -18.39 0.0001
2018-08-14 2018-06-30 13F CHROMADEX COM NEW 171077407 106,506 -8,918 395
2019-04-23 2018-03-31 13F/A-1 CHROMADEX COM NEW 171077407 115,424 99,124 608.12 484 404.17 0.0001
2018-05-14 2018-03-31 13F CHROMADEX COM NEW 171077407 115,424 99,124 484
2019-04-23 2017-12-31 13F/A-1 CHROMADEX COM NEW 171077407 16,300 14,200 676.19 96 966.67 0.0000
2018-02-14 2017-12-31 13F CHROMADEX COM NEW 171077407 16,300 14,200 96
2017-11-14 2017-09-30 13F CHROMADEX COM NEW 171077407 2,100 596 39.63 9 50.00 0.0000
2017-08-11 2017-06-30 13F CHROMADEX COM NEW 171077407 1,504 -36,186 -96.01 6 -94.06 0.0000
2017-05-22 2017-03-31 13F/A-1 CHROMADEX COM NEW 171077407 37,690 -45,620 -54.76 101 -63.41 0.0000
2017-05-12 2017-03-31 13F CHROMADEX COM NEW 171077407 37,690 101
2017-02-22 2016-12-31 13F/A-1 CHROMADEX COM NEW 171077407 83,310 78,077 1,492.01 276 1,625.00 0.0001
2017-02-13 2016-12-31 13F CHROMADEX COM NEW 171077407 83,310 276
2016-11-10 2016-09-30 13F CHROMADEX COM NEW 171077407 5,233 653 14.26 16 -15.79 0.0000
2016-08-12 2016-06-30 13F CHROMADEX COM NEW 171077407 4,580 4,580 19 0.0000
Legend
Shares
The total number of shares held by the institution at the end of the reporting period (the effective date). This is provided in the filing.
Value
The total value of the shares as of the effective date. This is provided in the filing.
Avg. Share Price
The weighted average share price of the shares held by the institution. We use FIFO accounting to determine this price
Class
This is the security class as indicated by the filer. There are a variety of values for this field. Common values include "EC" = equity common, "EP" - equity preferred
Allocation (%)
The percent of the institution's portfolio that this position represents. This is provided in NPORT filings. For 13F filings, we calculate it.
Change in Allocation
The change in allocation from the prior reporting period. This is calculated as current allocation - prior allocation.
Change in Allocation (%)
The percent change in allocation from the prior reporting period. This is calculated as (current allocation - prior allocation) / prior allocation.
Cost Basis
The total cost of the shares held. This is calculated as reported shares * avg. share price
Unrealized Gain/Loss
This is the market value of the position as of the effective date minus the cost basis.